ODI Pharma AB (publ) (NGM:ODI)

ODI Pharma AB Revenue

ODI Pharma AB had revenue of 6.00M SEK in the quarter ending September 30, 2025, with 4,070.89% growth. This brings the company's revenue in the last twelve months to 8.86M, down -59.76% year-over-year. In the fiscal year ending June 30, 2025, ODI Pharma AB had annual revenue of 3.11M, down -86.04%.

• Revenue (ttm): 8.86M
• Revenue Growth: -59.76%
• P/S Ratio: 3.52
• Revenue / Employee: 8.86M
• Employees: 1
• Market Cap: 31.16M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	3.11M	-19.18M	-86.04%
Jun 30, 2024	22.29M	22.15M	15,880.34%
Jun 30, 2023	139.46K	-173.48K	-55.44%
Jun 30, 2022	312.94K	-	-
Jun 30, 2021	-	-	-